Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Emergent Health Corp
(OP:
EMGE
)
0.0014
UNCHANGED
Streaming Delayed Price
Updated: 1:53 PM EDT, Sep 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.0014
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0014
Today's Range
0.0014 - 0.0014
52wk Range
0.0005 - 0.0041
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Apollo Biowellness, Inc./Resonate Blends, Inc., Provides Corporate Update Following Closing of Share Exchange Agreement
May 13, 2024
North Bergen, New Jersey--(Newsfile Corp. - May 13, 2024) - Apollo Biowellness, Inc., /Resonate Blends, Inc. (OTC Pink: KOAN) ("Resonate...
Via
Newsfile
Resonate Blends Executes a Share Exchange Agreement With Emergent Health Corp.
March 15, 2024
Via
ACCESSWIRE
Performance
YTD
+55.56%
+55.56%
1 Month
-17.65%
-17.65%
3 Month
-6.67%
-6.67%
6 Month
+7.69%
+7.69%
1 Year
+55.56%
+55.56%
More News
Read More
Emergent Health and Apollo Biowellness Announce Strategic Collaboration
May 23, 2023
Via
TheNewswire.com
Topics
Initial Public Offering
Exposures
Securities Market
Emergent Health and Apollo Biowellness Announce Strategic Collaboration
May 23, 2023
Via
News Direct
Topics
Initial Public Offering
Exposures
Securities Market
Emergent Health Executes Term Sheet and Engagement Letter with Boustead Securities to roll up its Subsidiary, Evolutionary Biologics and other regenerative medicine and products companies
May 18, 2023
Via
News Direct
Topics
Initial Public Offering
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Emergent Health Executes Term Sheet and Engagement Letter with Boustead Securities to roll up its Subsidiary, Evolutionary Biologics and other regenerative medicine and products companies
May 18, 2023
Via
TheNewswire.com
Topics
Initial Public Offering
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Reports Quarter over Quarter Revenue Increase of Over 2300%
May 16, 2023
Via
TheNewswire.com
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Reports Quarter over Quarter Revenue Increase of Over 2300%
May 16, 2023
Via
News Direct
Emergent Health Subsidiary Evolutionary Biologics Executes Product Manufacturing Agreement with Major Player in the Regenerative Medicine Space
May 11, 2023
Via
TheNewswire.com
Topics
Initial Public Offering
Exposures
Securities Market
Emergent Health Subsidiary Evolutionary Biologics Executes Product Manufacturing Agreement with Major Player in the Regenerative Medicine Space
May 11, 2023
Via
News Direct
Emergent Health Subsidiary PharmaZu Retains BF Borgers to Audit its Financial Statement as required by the Engagement Letter with Boustead Securities
May 09, 2023
Via
News Direct
Topics
Initial Public Offering
Exposures
Securities Market
Emergent Health Subsidiary PharmaZu Retains BF Borgers to Audit its Financial Statement as required by the Engagement Letter with Boustead Securities
May 09, 2023
Via
TheNewswire.com
Topics
Initial Public Offering
Exposures
Securities Market
Emergent Health to spin out subsidiary PharmaZu to its Shareholders pursuant to an IPO underwritten by a Nationally Recognized Investment Banking Firm
May 04, 2023
Via
News Direct
Topics
Initial Public Offering
Exposures
Securities Market
Emergent Health to spin out subsidiary PharmaZu to its Shareholders pursuant to an IPO underwritten by a Nationally Recognized Investment Banking Firm
May 04, 2023
Via
TheNewswire.com
Topics
Initial Public Offering
Exposures
Securities Market
Emergent Health Announces Its Return to the “Pink Current Information” Tier on OTC Markets
May 03, 2023
Via
News Direct
Emergent Health Announces Its Return to the “Pink Current Information” Tier on OTC Markets
May 03, 2023
Via
TheNewswire.com
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Corp. Reports Year to Year Revenue Increase of Over 380% and Quarter to Quarter Revenue Increase of Over 100%
May 02, 2023
Via
News Direct
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Corp. Reports Year to Year Revenue Increase of Over 380% and Quarter to Quarter Revenue Increase of Over 100%
May 02, 2023
Via
TheNewswire.com
Topics
Intellectual Property
Exposures
Intellectual Property
Emergent Announces 'Month in Review' with CEO Jim Morrison
March 02, 2023
Via
ACCESSWIRE
Emergent Health Announces Revenue Forecast of $16 Million & Introduces ‘MAXIMUS Men’s Health’
February 28, 2023
Via
ACCESSWIRE
Emergent Health (EMGE) Completes Acquisition of Nanosthetic - Adding $3.5 Million to its Growing Revenue Streams
February 23, 2023
Via
ACCESSWIRE
Emergent Health (EMGE) Executes "Letter of Intent" to Acquire Privately Held Company with a total of $5.4 Million in Current Revenues
February 21, 2023
Via
ACCESSWIRE
(EMGE) Emergent Health Enters Acquisition Talks with Revenue-Producing Medical Company
February 17, 2023
Via
ACCESSWIRE
Emergent Health Announces that Retail Power Hitter and Former Kraft Foods Director of National Accounts, Charlie McMenamin, Plans Product Placements in Nation's Biggest Retail Companies
February 14, 2023
Via
ACCESSWIRE
Emergent Projects $3.5 Million in Revenues With Acquisition of Nanosthetic Corp. Fueling Evolutionary Biologics
February 07, 2023
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.